Mercado de inhaladores médicos: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00018804
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

INTRODUCCIÓN AL MERCADO Los inhaladores médicos son dispositivos médicos que se utilizan para administrar diversos medicamentos mediante inhalación. Los medicamentos utilizados en los inhaladores incluyen anticolinérgicos, glucocorticoides, insulina y betaagonistas para el tratamiento y prevención de enfermedades respiratorias como el asma y las enfermedades pulmonares obstructivas crónicas. Los inhaladores inteligentes son un tipo de inhaladores médicos que tienen sensores conectados como un clip a los inhaladores que monitorean la dosis correcta por toma y la técnica utilizada para inhalar el medicamento. Los datos obtenidos por el sensor se comparten con el paciente y los profesionales sanitarios para realizar un seguimiento del uso del inhalador. Otros tipos diferentes de inhaladores incluyen el inhalador de polvo seco, el inhalador de dosis medidas y otros. DINÁMICA DEL MERCADO El mercado de inhaladores médicos ha mostrado una evolución significativa durante el período de pronóstico. El aumento del mercado de inhaladores médicos está impulsado por la mayor prevalencia de personas que padecen asma y enfermedades pulmonares obstructivas crónicas y los avances tecnológicos en el desarrollo de mejores dispositivos y sistemas inhaladores inteligentes. Además, las iniciativas gubernamentales para improvisar la infraestructura sanitaria estándar y centrarse más en el gasto sanitario están ayudando a estos países a centrarse en ofrecer atención sanitaria de alta calidad. Se han realizado grandes esfuerzos para controlar trastornos como el asma y el trastorno pulmonar obstructivo crónico (EPOC), que afecta a la mayoría de la gente. Según la OMS, en 2016 más de 300 millones de personas en el mundo padecen asma y más de 200 millones de personas padecen EPOC. Sin embargo, se espera que el mayor coste asociado al desarrollo de inhaladores médicos para el asma y la EPOC limite el Crecimiento del mercado de inhaladores médicos. ÁMBITO DEL MERCADO El "Análisis del mercado de inhaladores médicos hasta 2031" es un estudio especializado y en profundidad de los dispositivos médicos de la industria de la salud, que se centra en el análisis de las tendencias del mercado global. Este informe describe el mercado de inhaladores médicos con una segmentación detallada del mercado por producto, aplicación y usuario final. Se estima que el mercado de inhaladores médicos experimentará un gran aumento durante el período de pronóstico. Se centra en las estadísticas vitales sobre el estado del mercado de los principales actores en el mercado de inhaladores médicos y proporciona oportunidades y tendencias clave en el mercado. SEGMENTACIÓN DEL MERCADO El mercado se clasifica según el producto, la aplicación y el usuario final. Según el producto, el mercado se segmenta en inhalador de polvo seco, inhalador de dosis medidas y otros. Según la aplicación, la segmentación del mercado se centra en asma, trastorno pulmonar obstructivo crónico y otros. Según el usuario final, la segmentación del mercado se realiza en hospitales, clínicas, centros de atención respiratoria y otros. El informe establece un esquema detallado de la industria, que consta de información tanto cuantitativa como cualitativa. Ofrece un bosquejo y un pronóstico del mercado de inhaladores médicos en función de varios segmentos. El informe también consta del tamaño del mercado y estimaciones de pronóstico para el año 2021 al 2031 con respecto a cinco regiones principales, a saber; América del Norte, Asia-Pacífico (APAC), Europa, Medio Oriente y África (MEA) y América del Sur y Central (SCAM). Luego, el mercado de inhaladores médicos de cada región se subsegmenta en los respectivos países y segmentos. Comprende el análisis y pronóstico de 18 países a nivel mundial y las tendencias y oportunidades recientes que prevalecen en la región. El informe analiza los factores que afectan el mercado de inhaladores médicos tanto desde el lado de la demanda como de la oferta. Además, evalúa la dinámica del mercado con respecto al mercado durante el período de pronóstico, es decir, impulsores, restricciones, oportunidades y tendencias futuras. También consta de un análisis PEST preciso para las cinco regiones, a saber, América del Norte, Asia Pacífico, Europa, Medio Oriente y África, y América del Sur y Central, después de evaluar los factores políticos, sociales, económicos y tecnológicos que afectan el mercado de Inhaladores médicos. en estas regiones. JUGADORES DEL MERCADO El informe contiene desarrollos críticos en el mercado de inhaladores médicos como estrategias de crecimiento orgánico e inorgánico. Varias empresas están recurriendo a estrategias de crecimiento orgánico, como lanzamientos de productos, aprobaciones de productos y otras, como patentes y eventos. Las estrategias de crecimiento inorgánico observadas fueron colaboraciones, adquisiciones y asociaciones. Diversas actividades de este tipo han allanado el camino para elaborar la base de negocios y clientes de los actores del mercado. Se estima que los actores del mercado de inhaladores médicos tendrán oportunidades de crecimiento rentables en los próximos años con la mayor demanda de inhaladores médicos en el mercado global. A continuación se muestra la lista de algunas empresas que participan en el mercado de inhaladores médicos. El informe también ofrece perfiles de actores clave en el mercado de inhaladores médicos, junto con su análisis FODA y estrategias de mercado. Además, el informe se centra en los actores clave del mercado con información sobre los perfiles de la empresa, información financiera de los últimos tres años, componentes y servicios prestados, desarrollo crítico en los últimos cinco años. - GlaxoSmithKline plc. - Koninklijke Philips NV - AstraZeneca - Cipla Inc. - Boehringer Ingelheim International GmbH - Beximco Pharmaceuticals Ltd - Merck & Co., Inc. - Teva Pharmaceutical Industries Ltd - Chiesi Farmaceutici SpA - Medisol Lifescience Pvt. Limitado. Ltd El equipo analítico y de investigación dedicado de Insight Partner está compuesto por profesionales experimentados con conocimientos estadísticos avanzados y ofrece varias opciones de personalización en el informe actual.
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region dominated the Medical Inhaler Market in 2023?

North America dominated the Medical Inhaler Market in 2023

What is one of the main future trends of the Medical Inhaler Market ?

Increasingly Patient-Centric Designs is likely to remain the key trend during the forecast period.

Which region is expected to witness the fastest growth rate by 2031?

Asia Pacific region is likely to witness the fastest growth rate during the forecast period.

What are the driving factors impacting the Medical Inhaler Market ?

The Medical Inhaler Market drivers include the Increasing Prevalence of Respiratory Disorders, Technological Advancements in Inhaler Devices, Growing Awareness and Education over Respiratory Health

Who are the prominent players in Medical Inhaler Market ?

GlaxoSmithKline plc., Koninklijke Philips N.V., AstraZeneca, Cipla Inc., Boehringer Ingelheim International GmbH, Beximco Pharmaceuticals Ltd are some prominent players in the Medical Inhaler Market

What is the expected CAGR of the Medical Inhaler Market ?

The Medical Inhaler Market is estimated to witness a CAGR of 9.7% from 2023 to 2031

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. GlaxoSmithKline plc.
2. Koninklijke Philips N.V.
3. AstraZeneca
4. Cipla Inc.
5. Boehringer Ingelheim International GmbH
6. Beximco Pharmaceuticals Ltd
7. Merck & Co., Inc.
8. Teva Pharmaceutical Industries Ltd
9. Chiesi Farmaceutici SpA
10. Medisol Lifescience Pvt. Ltd

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.